Trump Administration Considers New FDA Chief Amid Vaccine Policy Controversy

The Trump administration is evaluating Dr. Norman 'Ned' Sharpless, a former head of the National Cancer Institute, as a potential leader for the FDA. Sharpless has publicly criticized vaccine policies linked to Health and Human Services Secretary Robert F. Kennedy Jr., indicating a shift in the administration's approach to health leadership. This decision comes as the administration aims to stabilize the FDA, which has faced challenges and political scrutiny. The search for a permanent FDA commissioner is ongoing, with a decision expected soon, although timelines may shift. Other candidates include pharmaceutical executive Richard Pops and current acting commissioner Kyle Diamantas, highlighting a broader effort to reshape health department leadership ahead of the midterms.

Key Details: • Dr. Norman Sharpless is a candidate for FDA chief, previously led the National Cancer Institute. • The administration aims to submit a nominee by mid-October, but timelines may change. • Other candidates under consideration include Richard Pops and Kyle Diamantas.